PRNewsWire
09 Apr 2026, 13:00 UTC · 30w ago
Verdict
Headline takes no side. We score LFST +0.80 across two claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
LifeStance Health published clinical data showing clinically significant symptom improvements for nearly 180,000 patients treated for anxiety and depression.
More positive than 76% of claims this week
LifeStance is utilizing a measurement-informed care model using GAD-7 and PHQ-9 tools to track and adjust patient treatment over time.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 48% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company published clinical outcomes data demonstrating significant symptom improvement for patients, validating its care model at scale.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
1h ago
+112.5%
Price agrees with the score
$13.90 vs $6.54 close before publication (Apr 8) · not market-adjusted
LFST chart →
